Trump signed an executive order aimed at reducing approval times for pharmaceutical plants in the country. The order directs the FDA to reduce approval times for domestic pharmaceutical manufacturing plants by eliminating unnecessary requirements. He also said there will be a few major announcements in coming weeks regarding the costs of drugs and medicines.
first published: May 6, 2025 04:48 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell
Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
